Amanda Potter
Amanda Potter’s practice focuses on patent litigation, including high-stakes life sciences and medical device matters.
Amanda assists clients with due diligence, patent portfolio assessment, and developing and coordinating global freedom-to-operate and enforcement strategies. She has represented clients in matters related to biologic and small-molecule drugs, medical devices, vaccines, dermatologic products, and software. Her practice includes representing clients in U.S. federal district and appellate courts, inter partes review proceedings before the Patent Trial and Appeal Board, and ICC arbitration.
Amanda is experienced in all phases of complex patent infringement disputes, including pre-suit investigations, expert and fact discovery, trial preparation, trial, and appeals to the Federal Circuit.
Experience
International Biopharmaceutical Company
Represented international biopharmaceutical company in confidential matter involving offensive and defensive patent assertion strategy concerning vaccines.
Patent Holder Avanos
Represented patent holder Avanos in patent infringement suit involving cooled radiofrequency ablation products.
Actelion Pharmaceuticals Ltd.
Represented patent holder Johnson & Johnson subsidiary, Actelion Pharmaceuticals Ltd., in patent infringement suits filed under the Hatch-Waxman Act involving pulmonary arterial hypertension drug Tracleer®.
Janssen
Represented patent holder Johnson & Johnson subsidiary, Janssen, in patent infringement suits filed under the Hatch-Waxman Act and inter partes review proceedings involving prostate cancer drug, Zytiga®.